Stay updated with breaking news from Severe Fever. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cleveland Clinic researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that currently has no prevention, treatment or cure.
Cleveland Clinic researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that currently has no prevention, treatment or cure. The patent-pending vaccine uses nanoparticles to carry the antigens that contain instructions for fighting off a virus. Nanoparticle vaccines are designed to effectively deliver antigens at a lower dose with fewer side effects for at-risk groups – including adults over age 50, who are the most vulnerable to SFTSV and the most...
A woman contracted Severe Fever with Thrombocytopenia Syndrome, a tick-borne disease, after coming into contact with a stray cat in Seogipo-si, Jeju, health authorities said on Monday. SFTS is an infectious disease that emerged from China with a mortality rate of up to 17 percent in Korea. The condition has no cure or vaccine as of now. The first local case was reported in 2013, and a total of 608 people have been in...
In 2021, Cleveland Clinic researchers were awarded more than $17 million in NIH grants related to pathogen research into COVID-19 vaccine candidates, development of broad-spectrum antiviral drugs and a vaccine for an emerging tick-borne virus.